Patients
Ten subjects with idiopathic PD (as defined by the UK Brain Bank criteria) were recruited from the Outpatient Clinic of the Movement Disorders Unit. In order to select subjects with FOG, we delivered the “Freezing of Gait Questionnaire” (Ebersbach et al. 1999) to 120 PD patients. Based on the answers, we selected ten patients with daily and disabling FOG episodes (during the off drug phase). Subjects were excluded if they were unable to walk alone without assistance in the off drug condition (Hoehn and Yahr stage ≥4), if they had significant co-morbidity that was likely to affect gait, or if patients were demented (we excluded patients with a Mattis scale score < 130).
We determined the unified Parkinson’s disease rating scale (UPDRS) motor score for each patient in the practically defined off drug condition (i.e., following withdrawal of all antiparkinson medication for at least 12 h). All gait analyses were also done in the off drug condition. The study was approved by the local investigational review board and each patient signed an informed consent form prior to testing.
Gait protocol
Patients were instructed to walk without physical support along a 7-m walkway. A six-camera, optoelectronic system (VICON 370 from Oxford Metrics, Oxford, UK, sampling frequency 50 Hz) was used to determine gait kinematics (Giladi et al. 2000).
Our specific test procedure consisted of three parts. At the start of day 1, patients were asked to walk normally at a comfortable speed (i.e., under spontaneous conditions). Five trials were performed and then analyzed in order to calculate the mean spontaneous gait velocity (m/s) and cadence (strides/min) for at least ten strides.
In the second part of day 1 (about 1 h after the baseline condition), subjects were asked to follow a mobile target mounted on a rail attached to the ceiling. Four different target velocities (calculated relative to each individual patient’s mean, spontaneous velocity) were imposed. The imposed velocities were set to 20 and 40% below (Velocity Minus: VM40, VM20) and 20 and 40% above (Velocity Plus: VP20, VP40) the individual’s spontaneous velocity. Twenty and 40% were calculated according to normal range of age matched subjects for normal and high gait speeds in the Laboratory, in order to specify the strategy that PD patient would adopt and effects on FOG.
In the third part of the experiment (performed on day 2), patients were instructed to adapt their stepping rate to the rhythm set by a metronome. The four imposed frequencies were calculated relative to each individual patient’s mean spontaneous cadence. The imposed cadences values were set to 20 and 40% below (Cadence Minus, CM40, CM20) and above (Cadence Plus, CP20 and CP40) the individual’s spontaneous cadence.
Five trials were recorded for each imposed velocity or cadence. The subject was not informed in advance of which condition was under investigation and was merely instructed to follow the target or the rhythm. The order of each of these conditions was altered randomly between subjects.
Observation-based definition of freezing events
The “gold standard” was the occurrence of clinically overt FOG episodes, as defined by independent clinical inspection of the patient by two neurologists with extensive experience in movement disorders. FOG was only accepted when both raters independently agreed that FOG was present. FOG episodes were defined by a sudden and involuntary cessation of gait (“block”) (Bloem et al. 2004; Ebersbach et al. 1999). In order to include “certain” FOG, we only included episodes lasting at least 5 s. However, separate analyses of brief FOG episodes (which may be more common in daily life) revealed very similar results (data not shown).
Data analysis
Spatial and temporal kinematic parameters (including velocity (m/s), cadence (stride/min), stride length (m), stride time (s)) were calculated using the Workstation and Polygon© software packages from Oxford Metrics. We analyzed outside FOG strides for spontaneous gait and each imposed gait condition, as well as the five strides preceding each FOG episode under imposed conditions.
First, for each kinematic parameter, the mean value for each imposed cadence or velocity condition was compared with the mean for the spontaneous condition. Second, our chosen index of stride-to-stride variability was the coefficient of variation for each kinematic parameter (CV = 100 × standard deviation/mean). We compared CVs in spontaneous versus imposed cadence and velocity conditions for the following parameters: cadence, velocity, stride length and stride time. Finally, for the imposed condition with the highest incidence of FOG episodes, the kinematic parameters (median and CV) for the five strides preceding an episode were compared with the values recorded for five other consecutive strides (i.e., far from a FOG episode) under the same condition.
Statistical analysis
We performed Wilcoxon non-parametric tests for each of the comparisons. A Bonferroni post hoc test was additionally used for correction. A statistical significance level of 0.01 was chosen.
Clinical characteristics
Median age of the 10 patients was 70 years [first quartile (Q1) 68; third quartile (Q3) 70.2] and median disease duration was 18 years [13;20]. The median UPDRS III score in the off drug condition was 40 [34; 44.5].
One hundred twenty patients’ average score at the FOG questionnaire was 24 (±11) (Ebersbach et al. 1999). The average “FOG subscore” (including items 4, 5, 6, 7) was 7.5 (±4).